2025
-
Session to Introduce the ACR’s New SLE Guideline
Using a case-based format, Lisa Sammaritano, MD, and other panelists will demonstrate how to use the guideline in a clinical setting, highlighting updates for 2025, and describe how the new recommendations were developed.
-
Speakers to Outline Vaccination Strategies for the Immunocompromised
Panelists, including Jin Kyun Park, MD, will discuss vaccine response in immunocompromised patients and vaccines as preventative care for those patients.
-
Panel to Explore New Horizons in PsA Management
Jose U. Scher, MD, will discuss challenges associated with addressing early onset psoriatic arthritis (PsA). The session also will review therapies for managing PsA.
-
Experts to Share New Developments in the Treatment of Pulmonary Sarcoidosis
Presentations in this Sunday session will include an assessment of the latest advances in better understanding the multiple phenotypes of pulmonary sarcoidosis from Michelle Sharp, MD, MHS.
-
Session to Explain How to Apply New Guidelines for Peripheral Neuropathies in Sjögren’s Disease
Guideline authors, including R. Hal Scofield, MD, will review the practical implications of the guidelines for care of patients and discuss specific case presentations. The guidelines stress the need for a multidisciplinary approach to manage Sjögren’s-related neuropathy effectively.
-
Speakers to Discuss Benefits of Direct Patient Care Practice Model for Both Providers and Patients
Private practice rheumatologists, including Saimun Singla, DO, FACR, will explain how they successfully implemented the direct care model and how it has affected their job satisfaction and patient care.
-
Enrichment of Putative Bacteria-Reactive Gut-Derived IL-17+ Tissue Resident Memory Helper T Cells in Arthritic Ankles in the SKG Mouse Model of Spondyloarthritis
Benjamin Cai, BS, and Ranjeny Thomas, MD
